1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Japanese Encephalitis (JE) Vaccine Revenue
1.4 Market Analysis by Type
1.4.1 Global Japanese Encephalitis (JE) Vaccine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Inactivated Vaccine
1.4.3 Live Attenuated Vaccine
1.5 Market by Application
1.5.1 Global Japanese Encephalitis (JE) Vaccine Market Share by Application: 2021-2026
1.5.2 Public
1.5.3 Private
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Japanese Encephalitis (JE) Vaccine Market
1.8.1 Global Japanese Encephalitis (JE) Vaccine Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Japanese Encephalitis (JE) Vaccine Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Japanese Encephalitis (JE) Vaccine Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Japanese Encephalitis (JE) Vaccine Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Japanese Encephalitis (JE) Vaccine Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Japanese Encephalitis (JE) Vaccine Sales Volume Market Share by Region (2015-2020)
3.2 Global Japanese Encephalitis (JE) Vaccine Sales Revenue Market Share by Region (2015-2020)
3.3 North America Japanese Encephalitis (JE) Vaccine Sales Volume
3.3.1 North America Japanese Encephalitis (JE) Vaccine Sales Volume Growth Rate (2015-2020)
3.3.2 North America Japanese Encephalitis (JE) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Japanese Encephalitis (JE) Vaccine Sales Volume
3.4.1 East Asia Japanese Encephalitis (JE) Vaccine Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Japanese Encephalitis (JE) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Japanese Encephalitis (JE) Vaccine Sales Volume (2015-2020)
3.5.1 Europe Japanese Encephalitis (JE) Vaccine Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Japanese Encephalitis (JE) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Japanese Encephalitis (JE) Vaccine Sales Volume (2015-2020)
3.6.1 South Asia Japanese Encephalitis (JE) Vaccine Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Japanese Encephalitis (JE) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Japanese Encephalitis (JE) Vaccine Sales Volume (2015-2020)
3.7.1 Southeast Asia Japanese Encephalitis (JE) Vaccine Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Japanese Encephalitis (JE) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Japanese Encephalitis (JE) Vaccine Sales Volume (2015-2020)
3.8.1 Middle East Japanese Encephalitis (JE) Vaccine Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Japanese Encephalitis (JE) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Japanese Encephalitis (JE) Vaccine Sales Volume (2015-2020)
3.9.1 Africa Japanese Encephalitis (JE) Vaccine Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Japanese Encephalitis (JE) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Japanese Encephalitis (JE) Vaccine Sales Volume (2015-2020)
3.10.1 Oceania Japanese Encephalitis (JE) Vaccine Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Japanese Encephalitis (JE) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Japanese Encephalitis (JE) Vaccine Sales Volume (2015-2020)
3.11.1 South America Japanese Encephalitis (JE) Vaccine Sales Volume Growth Rate (2015-2020)
3.11.2 South America Japanese Encephalitis (JE) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Japanese Encephalitis (JE) Vaccine Sales Volume (2015-2020)
3.12.1 Rest of the World Japanese Encephalitis (JE) Vaccine Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Japanese Encephalitis (JE) Vaccine Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Japanese Encephalitis (JE) Vaccine Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Japanese Encephalitis (JE) Vaccine Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Japanese Encephalitis (JE) Vaccine Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Japanese Encephalitis (JE) Vaccine Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Japanese Encephalitis (JE) Vaccine Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Japanese Encephalitis (JE) Vaccine Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Japanese Encephalitis (JE) Vaccine Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Japanese Encephalitis (JE) Vaccine Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Japanese Encephalitis (JE) Vaccine Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Japanese Encephalitis (JE) Vaccine Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Japanese Encephalitis (JE) Vaccine Sales Volume Market Share by Type (2015-2020)
14.2 Global Japanese Encephalitis (JE) Vaccine Sales Revenue Market Share by Type (2015-2020)
14.3 Global Japanese Encephalitis (JE) Vaccine Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Japanese Encephalitis (JE) Vaccine Consumption Volume by Application (2015-2020)
15.2 Global Japanese Encephalitis (JE) Vaccine Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Japanese Encephalitis (JE) Vaccine Business
16.1 GSK
16.1.1 GSK Company Profile
16.1.2 GSK Japanese Encephalitis (JE) Vaccine Product Specification
16.1.3 GSK Japanese Encephalitis (JE) Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Bharat Biotech
16.2.1 Bharat Biotech Company Profile
16.2.2 Bharat Biotech Japanese Encephalitis (JE) Vaccine Product Specification
16.2.3 Bharat Biotech Japanese Encephalitis (JE) Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Wuhan Institute of Biological
16.3.1 Wuhan Institute of Biological Company Profile
16.3.2 Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Product Specification
16.3.3 Wuhan Institute of Biological Japanese Encephalitis (JE) Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Sanofi
16.4.1 Sanofi Company Profile
16.4.2 Sanofi Japanese Encephalitis (JE) Vaccine Product Specification
16.4.3 Sanofi Japanese Encephalitis (JE) Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Valneva
16.5.1 Valneva Company Profile
16.5.2 Valneva Japanese Encephalitis (JE) Vaccine Product Specification
16.5.3 Valneva Japanese Encephalitis (JE) Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Chengdu institute of biologica
16.6.1 Chengdu institute of biologica Company Profile
16.6.2 Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Product Specification
16.6.3 Chengdu institute of biologica Japanese Encephalitis (JE) Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Liaoning Chengda
16.7.1 Liaoning Chengda Company Profile
16.7.2 Liaoning Chengda Japanese Encephalitis (JE) Vaccine Product Specification
16.7.3 Liaoning Chengda Japanese Encephalitis (JE) Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Beijing Taitan
16.8.1 Beijing Taitan Company Profile
16.8.2 Beijing Taitan Japanese Encephalitis (JE) Vaccine Product Specification
16.8.3 Beijing Taitan Japanese Encephalitis (JE) Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Lanzhou Institute of Biological
16.9.1 Lanzhou Institute of Biological Company Profile
16.9.2 Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Product Specification
16.9.3 Lanzhou Institute of Biological Japanese Encephalitis (JE) Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Biological E. Limited
16.10.1 Biological E. Limited Company Profile
16.10.2 Biological E. Limited Japanese Encephalitis (JE) Vaccine Product Specification
16.10.3 Biological E. Limited Japanese Encephalitis (JE) Vaccine Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Japanese Encephalitis (JE) Vaccine Manufacturing Cost Analysis
17.1 Japanese Encephalitis (JE) Vaccine Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Japanese Encephalitis (JE) Vaccine
17.4 Japanese Encephalitis (JE) Vaccine Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Japanese Encephalitis (JE) Vaccine Distributors List
18.3 Japanese Encephalitis (JE) Vaccine Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Japanese Encephalitis (JE) Vaccine (2021-2026)
20.2 Global Forecasted Revenue of Japanese Encephalitis (JE) Vaccine (2021-2026)
20.3 Global Forecasted Price of Japanese Encephalitis (JE) Vaccine (2015-2026)
20.4 Global Forecasted Production of Japanese Encephalitis (JE) Vaccine by Region (2021-2026)
20.4.1 North America Japanese Encephalitis (JE) Vaccine Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Japanese Encephalitis (JE) Vaccine Production, Revenue Forecast (2021-2026)
20.4.3 Europe Japanese Encephalitis (JE) Vaccine Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Japanese Encephalitis (JE) Vaccine Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Japanese Encephalitis (JE) Vaccine Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Japanese Encephalitis (JE) Vaccine Production, Revenue Forecast (2021-2026)
20.4.7 Africa Japanese Encephalitis (JE) Vaccine Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Japanese Encephalitis (JE) Vaccine Production, Revenue Forecast (2021-2026)
20.4.9 South America Japanese Encephalitis (JE) Vaccine Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Japanese Encephalitis (JE) Vaccine Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Japanese Encephalitis (JE) Vaccine by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Japanese Encephalitis (JE) Vaccine by Country
21.2 East Asia Market Forecasted Consumption of Japanese Encephalitis (JE) Vaccine by Country
21.3 Europe Market Forecasted Consumption of Japanese Encephalitis (JE) Vaccine by Countriy
21.4 South Asia Forecasted Consumption of Japanese Encephalitis (JE) Vaccine by Country
21.5 Southeast Asia Forecasted Consumption of Japanese Encephalitis (JE) Vaccine by Country
21.6 Middle East Forecasted Consumption of Japanese Encephalitis (JE) Vaccine by Country
21.7 Africa Forecasted Consumption of Japanese Encephalitis (JE) Vaccine by Country
21.8 Oceania Forecasted Consumption of Japanese Encephalitis (JE) Vaccine by Country
21.9 South America Forecasted Consumption of Japanese Encephalitis (JE) Vaccine by Country
21.10 Rest of the world Forecasted Consumption of Japanese Encephalitis (JE) Vaccine by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer